University of Queensland, Brisbane, Australia and Dalhousie University, Halifax, Nova Scotia, Canada
Health Outcomes Research Unit, Capital District Health Authority, Halifax, Nova Scotia, Canada
Population Health Research Unit, Dalhousie University, Halifax, Nova Scotia, Canada
Correspondence: Correspondence: Stephen Kisely, Room 518(A), McGregor Building (No 64), Queensland Centre for Health Data Services, The University of Queensland, St Lucia, Brisbane, Queensland 4072, Australia. Email: s.kisely{at}uq.edu.au
Background
Most data on the quality of vascular care for individuals with psychiatric conditions come from countries without universal healthcare.
Aims
To investigate the treatment of people with psychosis admitted for ischaemic heart disease or stroke under universal healthcare.
Method
A population-based study of administrative data comparing Canadians with and without a history of schizophrenia or related psychosis (n = 65 039).
Results
Of 49 248 admissions for ischaemic heart disease, 1285 had a history of psychosis. Despite a higher 1-year mortality, they were less likely to receive guideline-consistent treatment: e.g. coronary artery bypass grafting (adjusted odds ratio (OR) = 0.35, 95% CI 0.25–0.48), beta-blockers (adjusted OR = 0.82, 95% CI 0.71–0.95) and statins (adjusted OR = 0.51, 95% CI 0.41–0.63). Of 15 791 admissions for stroke, 594 had a history of psychosis. Despite higher 1-year mortality rates, they were less likely to receive cerebrovascular arteriography or warfarin.
Conclusions
People with a history of psychosis do not receive equitable levels of vascular care under universal healthcare.
Related articles in BJP: